Gene:
BMP2
bone morphogenetic protein 2

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this . To report a drug label with PGx, click here.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

This is a non-comprehensive list of genetic tests with pharmacogenetics relevance, typically submitted by the manufacturer and manually curated by PharmGKB. The information listed is provided for educational purposes only and does not constitute an endorsement of any listed test or manufacturer.

A more complete listing of genetic tests is found at the Genetic Testing Registry (GTR).

PGx Test Variants Assayed Related Drugs?

Overview

Alternate Names:  None
Alternate Symbols:  None
PharmGKB Accession Id: PA25379

Details

Cytogenetic Location: chr20 : p12.3 - p12.3
GP mRNA Boundary: chr20 : 6748745 - 6760910
GP Gene Boundary: chr20 : 6738745 - 6763910
Strand: plus
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

PharmGKB contains no curated pathways for this gene. If you would like to volunteer to work on a pathway, please let us know.

External Pathways

Links to non-PharmGKB pathways.

  1. alk in cardiac myocytes - (BioCarta via Pathway Interaction Database)
  2. Signaling by BMP - (Reactome via Pathway Interaction Database)

Publications related to BMP2: 1

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance. American journal of human genetics. 2007. Milet Jacqueline, et al. PubMed

LinkOuts

Entrez Gene:
650
OMIM:
112261
235200
UCSC Genome Browser:
NM_001200
RefSeq RNA:
NM_001200
RefSeq Protein:
NP_001191
RefSeq DNA:
AC_000063
AC_000152
NC_000020
NG_023233
NT_011387
NW_001838652
NW_927317
UniProtKB:
C8C060_HUMAN (C8C060)
BMP2_HUMAN (P12643)
Ensembl:
ENSG00000125845
GenAtlas:
BMP2
GeneCard:
BMP2
MutDB:
BMP2
ALFRED:
LO015535T
HuGE:
BMP2
Comparative Toxicogenomics Database:
650
ModBase:
P12643
HumanCyc Gene:
HS04953
HGNC:
1069

Common Searches